Market access pathways for cell therapies in France

INTRODUCTION AND OBJECTIVE: Cell therapies can be classified into three main categories of products: advanced therapy medicinal products (ATMPs), ATMPs prepared on a non-routine basis (hospital exemptions), and minimally manipulated cells. Despite the benefits that cell therapies can bring to patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Rémuzat, Cécile, Toumi, Mondher, Jørgensen, Jesper, Kefalas, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802688/
https://www.ncbi.nlm.nih.gov/pubmed/27123176
http://dx.doi.org/10.3402/jmahp.v3.29094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802688/
https://www.ncbi.nlm.nih.gov/pubmed/27123176
http://dx.doi.org/10.3402/jmahp.v3.29094

Ejemplares similares